BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19788175)

  • 1. Single-step conjugation of bioactive peptides to proteins via a self-contained succinimidyl bis-arylhydrazone.
    Phillips JA; Morgan EL; Dong Y; Cole GT; McMahan C; Hung CY; Sanderson SD
    Bioconjug Chem; 2009 Oct; 20(10):1950-7. PubMed ID: 19788175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel adjuvant for vaccine development in the aged.
    Morgan EL; Thoman ML; Sanderson SD; Phillips JA
    Vaccine; 2010 Dec; 28(52):8275-9. PubMed ID: 20965299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
    Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
    Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.
    Morgan EL; Morgan BN; Stein EA; Vitrs EL; Thoman ML; Sanderson SD; Phillips JA
    Vaccine; 2009 Dec; 28(2):463-9. PubMed ID: 19836478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection.
    Tallapaka SB; Karuturi BVK; Yeapuri P; Curran SM; Sonawane YA; Phillips JA; David Smith D; Sanderson SD; Vetro JA
    Int J Pharm; 2019 Jun; 565():242-257. PubMed ID: 31077762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B; Soema PC; Ding Z; Verheul R; Hennink W; Jiskoot W
    J Control Release; 2010 Apr; 143(2):207-14. PubMed ID: 20074597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific peptide-based vaccines containing the conformationally biased, response-selective C5a agonists EP54 and EP67 protect against aggressive large B cell lymphoma in a syngeneic murine model.
    Kollessery G; Nordgren TM; Mittal AK; Joshi SS; Sanderson SD
    Vaccine; 2011 Aug; 29(35):5904-10. PubMed ID: 21723901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant.
    Karuturi BV; Tallapaka SB; Phillips JA; Sanderson SD; Vetro JA
    Clin Immunol; 2015 Dec; 161(2):251-9. PubMed ID: 26111481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity.
    Jain A; Yan W; Miller KR; O'Carra R; Woodward JG; Mumper RJ
    Int J Pharm; 2010 Nov; 401(1-2):87-92. PubMed ID: 20837122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A protective vaccine delivery system for in vivo T cell stimulation using nanoengineered polymer hydrogel capsules.
    Sexton A; Whitney PG; Chong SF; Zelikin AN; Johnston AP; De Rose R; Brooks AG; Caruso F; Kent SJ
    ACS Nano; 2009 Nov; 3(11):3391-400. PubMed ID: 19824668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical denaturation of ovalbumin abrogates the induction of oral tolerance of specific IgG antibody and DTH responses in mice.
    Peng HJ; Chang ZN; Han SH; Won MH; Huang BT
    Scand J Immunol; 1995 Sep; 42(3):297-304. PubMed ID: 7544908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a quartz crystal microbalance platform to study protein adsorption on aluminum hydroxide vaccine adjuvants: Focus on phosphate-hydroxide ligand exchanges.
    Art JF; Soumillion P; Dupont-Gillain CC
    Int J Pharm; 2020 Jan; 573():118834. PubMed ID: 31715342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice.
    Patel GB; Ponce A; Zhou H; Chen W
    J Liposome Res; 2008; 18(2):127-43. PubMed ID: 18569448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67.
    Alshammari AM; Smith DD; Parriott J; Stewart JP; Curran SM; McCulloh RJ; Barry PA; Iyer SS; Palermo N; Phillips JA; Dong Y; Ronning DR; Vennerstrom JL; Sanderson SD; Vetro JA
    ACS Infect Dis; 2020 May; 6(5):1169-1181. PubMed ID: 32233506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum.
    Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H
    J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a single-molecule L-rhamnose-containing three-component vaccine and evaluation of antigenicity in the presence of anti-L-rhamnose antibodies.
    Sarkar S; Lombardo SA; Herner DN; Talan RS; Wall KA; Sucheck SJ
    J Am Chem Soc; 2010 Dec; 132(48):17236-46. PubMed ID: 21080675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
    Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
    Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel vaccine delivery system based on Gantrez nanoparticles.
    Gómez S; Gamazo C; San Roman B; Vauthier C; Ferrer M; Irachel JM
    J Nanosci Nanotechnol; 2006; 6(9-10):3283-9. PubMed ID: 17048548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of a balanced Th1/Th2 immune responses by co-delivery of PLGA/ovalbumin nanospheres and CpG ODNs/PEI-SWCNT nanoparticles as TLR9 agonist in BALB/c mice.
    Ebrahimian M; Hashemi M; Maleki M; Abnous K; Hashemitabar G; Ramezani M; Haghparast A
    Int J Pharm; 2016 Dec; 515(1-2):708-720. PubMed ID: 27989827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy.
    Huang CH; Huang CY; Cheng CP; Dai SH; Chen HW; Leng CH; Chong P; Liu SJ; Huang MH
    Sci Rep; 2016 Nov; 6():36732. PubMed ID: 27827451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.